Nautilus Biotechnology Investor Relations Material

Nautilus Biotechnology, Inc. is a life sciences company specializing in the development of a next-generation platform for proteomics research. The company's technology is designed to identify and quantify proteins with high sensitivity, aiming to advance scientific discovery and improve healthcare outcomes. Nautilus focuses on enabling researchers to study the proteome at unprecedented depth and scale, which could support advancements in drug discovery, diagnostics, and personalized medicine. The company is headquartered in Seattle, Washington, and its shares are listed on the NASDAQ.